- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Smoldering Multiple Myeloma in New Zealand
Total 2222 results
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedAcute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Plasma Cell Myeloma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Minimal Residual Disease | Therapy-Related Acute Myeloid Leukemia | Therapy-Related Myelodysplastic... and other conditionsUnited States
-
AmgenCompletedEnd-stage Renal Disease | Relapsed Multiple MyelomaUnited States, Australia, Canada
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | Acute Myeloid Leukemia | Leukemia | Myelodysplastic Syndrome | Myeloma | Hematological MalignancyUnited States
-
Vastra Gotaland RegionAustralasian Leukaemia and Lymphoma Group; The Canadian Blood and Marrow Transplant...CompletedAcute Myeloid LeukemiaFinland, Australia, Canada, New Zealand, Sweden, Estonia, Germany, Greece, Norway
-
Antisoma ResearchCompletedLeukemia, MyeloidUnited States, New Zealand
-
Regeneron PharmaceuticalsRecruiting
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingPlasma Cell Myeloma | RISS Stage I Plasma Cell Myeloma | RISS Stage II Plasma Cell MyelomaUnited States
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaFrance, Czechia, Sweden, United States, Greece, Spain, Finland, Romania, Germany, Japan, Netherlands, Turkey, Austria, Bulgaria, Lithuania, Russian Federation, Slovakia
-
Geron CorporationCompletedMultiple MyelomaUnited States
-
Infinity Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and/or Refractory Multiple MyelomaUnited States, France, Norway, Spain, Israel, United Kingdom, Italy, Australia, Germany, Greece, Canada, Czechia, Turkey, Russian Federation, Denmark, Sweden, Belgium, Netherlands
-
PfizerBristol-Myers SquibbRecruiting
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
Weill Medical College of Cornell UniversityOnyx Therapeutics, Inc.Active, not recruiting
-
Weill Medical College of Cornell UniversityCelgeneActive, not recruiting
-
Icahn School of Medicine at Mount SinaiBristol-Myers Squibb; Multiple Myeloma Research ConsortiumEnrolling by invitation
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterOtsuka America Pharmaceutical; Ludwig Institute for Cancer ResearchCompleted
-
Weill Medical College of Cornell UniversityCelgene CorporationCompletedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityPfizer; Celgene CorporationTerminatedMultiple MyelomaUnited States
-
Sundar JagannathBristol-Myers SquibbNo longer available
-
SanofiActive, not recruitingPlasma Cell MyelomaMexico, Sweden, Poland, France, Czechia, Greece, Taiwan, Lithuania, Portugal, Spain, Australia, Italy, New Zealand, Russian Federation, Turkey, Japan, United States, Belgium, China, Denmark, Germany
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)TerminatedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Precancerous/Nonmalignant ConditionUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsRecruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
SanofiRecruitingRelapsed/Refractory Multiple Myeloma | Amyloid Light-chain AmyloidosisItaly, Australia, Hungary, United Kingdom, Czechia, Belgium, Spain
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI)Not yet recruiting
-
PfizerCompletedMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterJuno Therapeutics, Inc., a Bristol-Myers Squibb CompanyActive, not recruitingMultiple MyelomaUnited States
-
Ludwig Institute for Cancer ResearchCancer Research Institute, New York City; MedImmune LLC; Multiple Myeloma Research...TerminatedPhase 1 Study of Tremelimumab, Durvalumab, High-dose Chemotherapy, + Autologous Stem Cell TransplantMultiple MyelomaUnited States
-
Ajai ChariTerminatedMultiple MyelomaUnited States
-
Columbia UniversityCompletedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityCompletedMultiple MyelomaUnited States
-
Weill Medical College of Cornell UniversityCelgeneTerminated
-
NYU Langone HealthCelgeneTerminatedMultiple MyelomaUnited States
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple Myeloma | Previously Treated Amyloid Light-chain (AL) AmyloidosisBelgium, United States, United Kingdom, Spain, France, Netherlands
-
MedImmune LLCCompletedAcute Myeloid Leukemia | Multiple Myeloma | Diffuse Large B-cell LymphomaUnited States, France, Korea, Republic of
-
Fate TherapeuticsRecruiting
-
Memorial Sloan Kettering Cancer CenterRecruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterTrillium Therapeutics Inc.Active, not recruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen PharmaceuticalsActive, not recruitingMultiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
University of RochesterRecruitingMultiple MyelomaUnited States
-
Hackensack Meridian HealthCompletedMultiple MyelomaUnited States
-
SanofiCompletedPlasma Cell MyelomaUnited States
-
PfizerCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedMultiple MyelomaUnited States